Jennifer McClure to Nicotinic Agonists
This is a "connection" page, showing publications Jennifer McClure has written about Nicotinic Agonists.
Connection Strength
0.982
-
Tailoring nicotine replacement therapy: rationale and potential approaches. CNS Drugs. 2006; 20(4):281-91.
Score: 0.254
-
Cigarette smoking and nicotine dependence. Med Clin North Am. 2004 Nov; 88(6):1453-65, x.
Score: 0.234
-
Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011 May; 13(5):361-8.
Score: 0.091
-
Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med. 2010 May; 38(5):482-90.
Score: 0.086
-
Smoking outcome by psychiatric history after behavioral and varenicline treatment. J Subst Abuse Treat. 2010 Jun; 38(4):394-402.
Score: 0.085
-
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat. 2009 Jun; 36(4):428-34.
Score: 0.077
-
The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tob Res. 2008 Sep; 10(9):1511-6.
Score: 0.076
-
Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol. 2011 Aug; 120(3):596-606.
Score: 0.023
-
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J. 2012 Aug; 12(4):349-58.
Score: 0.023
-
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res. 2011 May; 13(5):319-27.
Score: 0.023
-
Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol. 1999 May; 7(2):135-44.
Score: 0.010